Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:07 pm Sale | 13G | CLOVIS ONCOLOGY INC CLVS | CITADEL ADVISORS LLC | 3,392,624 5.9% | -568,038 (-14.34%) | View |
| 2020-02-14 4:07 pm Sale | 13G | NEXTCURE INC NXTC | CITADEL ADVISORS LLC | 805,515 2.9% | -319,617 (-28.41%) | View |
| 2020-02-14 4:07 pm Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | CITADEL ADVISORS LLC | 1,017,482 5.9% | 58,881 (+6.14%) | View |
| 2020-02-14 4:07 pm Purchase | 13G | SUTTER ROCK CAP CORP COM SSSS | CITADEL ADVISORS LLC | 1,107,816 5.9% | 1,107,816 (New Position) | View |
| 2020-02-14 4:07 pm Purchase | 13G | BRISTOW GROUP INC BRS | CITADEL ADVISORS LLC | 20,873 0.2% | 20,873 (New Position) | View |
| 2020-02-14 4:07 pm Sale | 13G | SUTRO BIOPHARMA INC STRO | CITADEL ADVISORS LLC | 1,728,976 7.5% | -67 (-0.00%) | View |
| 2020-01-17 4:06 pm Purchase | 13G | AVIANCA HLDGS SA ADS EACH REPS AVH | CITADEL ADVISORS LLC | 83,291,671 19.9% | 83,291,671 (New Position) | View |
| 2019-12-20 4:02 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | CITADEL ADVISORS LLC | 3,092,929 4.5% | 3,092,929 (New Position) | View |
| 2019-12-03 5:01 pm Purchase | 13G | VERASTEM, INC. VSTM | CITADEL ADVISORS LLC | 7,385,615 9.1% | 7,385,615 (New Position) | View |
| 2019-10-10 09:09 am Purchase | 13G | ROKU INC ROKU | CITADEL ADVISORS LLC | 4,246,210 5% | 4,246,210 (New Position) | View |
| 2019-09-23 08:48 am Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | CITADEL ADVISORS LLC | 958,601 5.8% | 958,601 (New Position) | View |
| 2019-08-16 09:30 am Purchase | 13G | CLOVIS ONCOLOGY INC CLVS | CITADEL ADVISORS LLC | 3,960,662 7% | 3,960,662 (New Position) | View |
| 2019-05-17 09:27 am Purchase | 13G | NEXTCURE INC NXTC | CITADEL ADVISORS LLC | 1,125,132 5% | 1,125,132 (New Position) | View |
| 2019-05-09 09:10 am Purchase | 13G | SCIPLAY CORP SCPL | CITADEL ADVISORS LLC | 1,467,161 6.7% | 1,467,161 (New Position) | View |